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interferon type I: partners in crime in systemic
lupus erythematosus?’
Sebastian Dolff1*, Wayel H Abdulahad2 and Cees GM Kallenberg2
See related research by Brkic et al., http://arthritis-research.com/content/16/2/R62 and
related letter by Brkic et al., http://arthritis-research.com/content/16/3/410We read with great interest the article by Brkic and col-
leagues in a recent issue of Arthritis Research & Therapy
[1]. In that study, the authors investigated the distribu-
tion of T helper (Th) subsets which produce IL-17A,
IL-17 F, IL-21, and IL-22 in patients with systemic lupus
erythematosus (SLE) in relation to their genetic IFN type
I signature. Patients with an IFN type I-positive signa-
ture showed increased percentages of IL-17A- and
IL-21-producing CCR6+ T cells. From these results, the
authors conclude that IFN type I cells co-act with Th17
cytokines in the pathogenesis of SLE. Surprisingly, they
excluded CD25+ T cells from their analysis. In a previous
study, we showed that Th cells from SLE patients ex-
pressing CD25med and CD25high are also able to produce
IFN-γ and IL-17A [2]. Therefore, it would be relevant to
assess cytokine expression in CD4+CD25+ T cells from
IFN type I-positive and IFN type I-negative SLE patients.
Furthermore, it should be proven that the genetic signa-
ture is solely responsible for the increased IFN production
by Th cells. In addition, their finding that CCR6+ T cells
are capable of producing IL-21 indirectly confirms our
previous observation that IL-17+ T cells are a main source
of IL-21 in patients with SLE [3]. Possibly, IL-21 is orches-
trating the Th1/Th17 axis.
Finally, we agree that there might be a co-activity be-
tween IFN-I- and IL-17-producing cells as described by
Brkic and colleagues. However, considering our findings
that T cells with a regulatory phenotype are able to pro-
duce IFN-γ and IL-17A in patients with SLE, we suggest
that primarily the plasticity of T cells is altered in patients
with SLE [4].* Correspondence: sebastian.dolff@uk-essen.de
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IFN: Interferon; IL: Interleukin; SLE: Systemic lupus erythematosus; Th: T
helper.
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